BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7192994)

  • 1. Metabolism of vincamine in the rat in vivo and in vitro.
    Vereczkey L; Tamás J; Czira G; Szporny L
    Arzneimittelforschung; 1980; 30(11):1860-5. PubMed ID: 7192994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism of vincamine in the rat].
    Viganò V; Paracchini S; Piacenza G; Pesce E
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of ethyl apovincaminate in the rat.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1933-8. PubMed ID: 1037219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic data on tritium labelled ethyl apovincaminate.
    Vereczkey L; Zólyomi G; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1929-33. PubMed ID: 1037218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humans.
    Mayo BC; Biggs SR; Hawkins DR; Chasseaud LF; Darragh A; Baldock GA; Whitby BR
    J Pharmacobiodyn; 1982 Dec; 5(12):951-64. PubMed ID: 7169608
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
    Koble DL; Koons JC; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of vincamine teprosilate.
    Cadórniga R; Saiz Vadillo MC; Molina IT; Cadórniga L
    Int J Clin Pharmacol Res; 1984; 4(4):281-90. PubMed ID: 6500775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic fate of supidimide in the rat.
    Becker R; Frankus E; Graudums I; Günzler WA; Helm FC; Flohé L
    Arzneimittelforschung; 1982; 32(9):1101-11. PubMed ID: 6890834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and biliary excretion of prostacyclin metabolites in the rat.
    Taylor BM; Sun FF
    J Pharmacol Exp Ther; 1980 Jul; 214(1):24-30. PubMed ID: 6993658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Absorption, distribution and elimination of vincamine hydrochloride in the rat].
    Vigano V; Rognoni F; Piacenza G; Pesce E
    Farmaco Prat; 1978 May; 33(5):224-31. PubMed ID: 744225
    [No Abstract]   [Full Text] [Related]  

  • 15. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma concentrations and renal excretion of vincamine after oral administration in man (author's transl)].
    Siegers CP; Iven H; Strubelt O
    Arzneimittelforschung; 1977; 27(6a):1271-4. PubMed ID: 578451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary elimination of bendamustin (Cytostasan) in rats.
    Bezek S; Scasnár V; Trnovec T; Grupe R
    Pharmazie; 1991 Nov; 46(11):810-1. PubMed ID: 1811234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of atorvastatin in rats and dogs.
    Black AE; Hayes RN; Roth BD; Woo P; Woolf TF
    Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the vincamine-papaverine association. i. biochemical investigations.
    Costrini R; Galzigna L; Bianchi M; Nunziata A; Cattani L
    Agressologie; 1978; 19(3):211-4. PubMed ID: 736220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.